Statistics

Total Visits

Views
Bevacizumab intravitreo como tratamiento de las telangiectasias yuxtafoveales idiopaticas tipo i23

Select a period of time:

Number of views in the range

Views
Bevacizumab intravitreo como tratamiento de las telangiectasias yuxtafoveales idiopaticas tipo i5

Views

Views
October 20240
November 20240
December 20240
January 20251
February 20252
March 20252
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
Singapore2
United Kingdom1
 

Top cities views

Views
Dallas2